University College, London
Clinical trials sponsored by University College, London, explained in plain language.
-
New hope for advanced prostate cancer: targeted radiation and radioactive drug under trial
Disease control Recruiting nowThis large phase 3 trial tests whether adding targeted radiotherapy (SABR) or a radioactive drug (PSMA-Lutetium) to standard hormone therapy can slow cancer spread and improve survival in people with metastatic prostate cancer. About 3,360 participants across the UK will be rando…
Phase: PHASE3 • Sponsor: University College, London • Aim: Disease control
Last updated May 03, 2026 12:37 UTC
-
Brain implant offers hope for kids with severe epilepsy
Disease control Recruiting nowThis study tests whether deep brain stimulation (DBS) can safely reduce seizures in 22 children aged 5-14 with Lennox-Gastaut syndrome, a severe form of epilepsy. The device, called Picostim, is implanted in the brain and delivers electrical pulses. The trial is double-blind and …
Phase: NA • Sponsor: University College, London • Aim: Disease control
Last updated May 03, 2026 12:36 UTC
-
Immunotherapy before surgery shows promise for certain colorectal cancers
Disease control Recruiting nowThis study tests whether giving the immunotherapy drug pembrolizumab before surgery can help people with a specific type of colorectal cancer (called MMR-deficient or MSI-high). The drug helps the immune system fight cancer cells. The goal is to see if this approach is safe, impr…
Phase: PHASE2 • Sponsor: University College, London • Aim: Disease control
Last updated May 03, 2026 12:35 UTC
-
New trial aims to improve treatment for hodgkin lymphoma patients
Disease control Recruiting nowThis study compares two chemotherapy combinations (ABVD and A2VD) for people with early-stage Hodgkin lymphoma that hasn't been treated yet. About 1,042 participants will receive 3-4 cycles of chemo, and a PET scan after 2 cycles helps doctors decide if more treatment is needed. …
Phase: PHASE3 • Sponsor: University College, London • Aim: Disease control
Last updated May 03, 2026 12:34 UTC
-
Less surgery may be enough for Low-Risk thyroid cancer, major trial launches
Disease control Recruiting nowThis study looks at whether removing only half of the thyroid (hemithyroidectomy) works as well as removing the whole thyroid (total thyroidectomy) for people with low-risk thyroid cancer. About 456 adults with this cancer will be randomly assigned to one of the two surgeries. Th…
Phase: NA • Sponsor: University College, London • Aim: Disease control
Last updated May 03, 2026 12:34 UTC
-
Could a bedroom air filter protect cancer Survivors' hearts?
Disease control Recruiting nowThis study tests whether using a high-efficiency air filter in the bedroom overnight can lower inflammation (measured by a blood marker called CRP) in adult cancer survivors living in polluted urban areas. Ten participants will each try both filtered and unfiltered air for two-we…
Phase: NA • Sponsor: University College, London • Aim: Disease control
Last updated May 03, 2026 12:32 UTC
-
Major trial aims to slow Parkinson's with smart drug testing
Disease control Recruiting nowThis large clinical trial is testing several potential treatments at once to see if they can slow the progression of Parkinson's disease. About 1,200 people with Parkinson's will take either an experimental drug or a placebo for up to 36 months. The study uses a flexible design t…
Phase: PHASE3 • Sponsor: University College, London • Aim: Disease control
Last updated May 03, 2026 12:06 UTC
-
Proton beam trial offers new hope for mesothelioma patients
Disease control Recruiting nowThis study tests whether proton beam radiation can help people with a rare lung cancer called malignant pleural mesothelioma. About 148 adults whose cancer is only on one side of the chest will receive either proton therapy or standard care. The goal is to see if the treatment de…
Phase: NA • Sponsor: University College, London • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New drug aims to slow Alzheimer's by targeting tau tangles
Disease control Recruiting nowThis early-phase study tests whether a drug called NIO752 can reduce the brain's production of tau, a protein that forms harmful tangles in Alzheimer's disease. Ten adults with mild to moderate Alzheimer's will receive either the drug or a placebo via spinal injection. The main g…
Phase: PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
Engineered immune cells take on Hard-to-Treat myeloma
Disease control Recruiting nowThis early-stage trial tests a new type of CAR T cell therapy for people with multiple myeloma that has come back or not responded to other treatments. The therapy uses specially engineered immune cells to target two proteins (BCMA and CD19) on cancer cells. The main goals are to…
Phase: PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated Apr 26, 2026 20:01 UTC
-
New app could spot jaundice in babies with a simple photo
Diagnosis Recruiting nowThis study tests a smartphone app called neoSCB that screens for jaundice in newborns by taking a photo of the baby's eye. Jaundice is common and usually harmless, but severe cases need treatment to prevent brain damage. The app aims to accurately detect high bilirubin levels wit…
Sponsor: University College, London • Aim: Diagnosis
Last updated May 01, 2026 16:00 UTC
-
Robotic knee surgery showdown: cementless vs cemented – which feels more natural?
Symptom relief Recruiting nowThis study compares two types of robotic-arm assisted knee replacements in 120 people with knee osteoarthritis. One uses cement to fix the implant, the other does not. The main goal is to see which approach helps patients feel like their knee is more natural and less like an arti…
Phase: NA • Sponsor: University College, London • Aim: Symptom relief
Last updated May 03, 2026 12:32 UTC
-
Massive hunt for Huntington's clues: 2,500 volunteers needed
Knowledge-focused Recruiting nowThis study aims to collect spinal fluid and blood samples from 2,500 volunteers at different stages of Huntington's disease. Researchers will analyze these samples to find biological markers that can help develop new treatments. The study does not test any drug, but instead build…
Sponsor: University College, London • Aim: Knowledge-focused
Last updated May 03, 2026 12:38 UTC
-
Can better testing improve bladder surgery success?
Knowledge-focused Recruiting nowThis study looks at whether two types of bladder function tests (urodynamics and video-urodynamics) help improve surgical results for women with recurrent stress urinary incontinence. Thirty women who have already had unsuccessful incontinence surgery will be randomly assigned to…
Phase: NA • Sponsor: University College, London • Aim: Knowledge-focused
Last updated May 03, 2026 12:33 UTC
-
Scientists uncover why exercise fights depression
Knowledge-focused Recruiting nowThis study aims to understand why physical activity helps with depression. Researchers will compare aerobic exercise to stretching in 250 adults with moderate depression. They will measure changes in the brain, immune system, and motivation to find out how exercise works. The goa…
Phase: NA • Sponsor: University College, London • Aim: Knowledge-focused
Last updated Apr 30, 2026 16:02 UTC
-
Mindful tunes or meditation? study tests digital prep for psychedelic trips
Knowledge-focused Recruiting nowThis study is testing a 21-day self-guided digital program to help healthy volunteers prepare for a supervised psilocybin session. Forty people will be randomly assigned to either a meditation or music-listening program. The main goal is to see if the program is practical and eas…
Phase: PHASE1 • Sponsor: University College, London • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:05 UTC